-
EP3998268
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3998268
| EP3998268 - COMPOUND FOR INHIBITING EGFR KINASE AND PREPARATION METHOD AND USE THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 15.11.2024 Database last updated on 03.01.2025 | |
| Former | Grant of patent is intended Status updated on 18.07.2024 | ||
| Former | Request for examination was made Status updated on 15.04.2022 | ||
| Former | The international publication has been made Status updated on 15.01.2021 | Most recent event Tooltip | 15.11.2024 | (Expected) grant | published on 18.12.2024 [2024/51] | Applicant(s) | For all designated states Wigen Biomedicine Technology (Shanghai) Co., Ltd. No. 11, 67 Lane, Libing Road Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | [2022/19] | Inventor(s) | 01 /
XIE, Yuli No. 11, 67 Lane, Libing Road, Pilot Free Trade Zone, Pudong New Area Shanghai 201203 / CN | 02 /
CAO, Gang No. 11, 67 Lane, Libing Road, Pilot Free Trade Zone, Pudong New Area Shanghai 201203 / CN | 03 /
FAN, Houxing No. 11, 67 Lane, Libing Road, Pilot Free Trade Zone, Pudong New Area Shanghai 201203 / CN | [2022/19] | Representative(s) | Lipscombe, Martin John Nash Matthews LLP 24 Hills Road Cambridge CB2 1JP / GB | [2022/19] | Application number, filing date | 20835453.0 | 02.07.2020 | [2022/20] | WO2020CN99916 | Priority number, date | CN201910600229 | 04.07.2019 Original published format: CN201910600229 | [2022/19] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021000912 | Date: | 07.01.2021 | Language: | ZH | [2021/01] | Type: | A1 Application with search report | No.: | EP3998268 | Date: | 18.05.2022 | Language: | EN | [2022/20] | Type: | B1 Patent specification | No.: | EP3998268 | Date: | 18.12.2024 | Language: | EN | [2024/51] | Search report(s) | International search report - published on: | CN | 07.01.2021 | (Supplementary) European search report - dispatched on: | EP | 22.05.2023 | Classification | IPC: | C07D471/06, A61K31/506, A61P35/00, A61P35/02, C07D519/00 | [2023/25] | CPC: |
C07D519/00 (EP,US);
C07D471/06 (EP,CN,KR,US);
A61K31/506 (KR);
A61P35/00 (EP,CN,KR);
A61P35/02 (EP,CN,KR);
C07D471/10 (KR);
C07D487/10 (KR)
(-)
|
| Former IPC [2022/19] | C07D471/06, A61K31/506, A61P35/00, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/19] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBINDUNG ZUR HEMMUNG DER EGFR-KINASE UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON | [2022/19] | English: | COMPOUND FOR INHIBITING EGFR KINASE AND PREPARATION METHOD AND USE THEREOF | [2022/19] | French: | COMPOSÉ POUR INHIBER LA KINASE EGFR ET SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION | [2022/19] | Entry into regional phase | 20.01.2022 | Translation filed | 20.01.2022 | National basic fee paid | 20.01.2022 | Search fee paid | 20.01.2022 | Designation fee(s) paid | 20.01.2022 | Examination fee paid | Examination procedure | 20.01.2022 | Examination requested [2022/20] | 06.12.2023 | Amendment by applicant (claims and/or description) | 06.12.2023 | Date on which the examining division has become responsible | 19.07.2024 | Communication of intention to grant the patent | 08.11.2024 | Fee for grant paid | 08.11.2024 | Fee for publishing/printing paid | 08.11.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 27.07.2022 | Renewal fee patent year 03 | 25.05.2023 | Renewal fee patent year 04 | 10.06.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]WO2017120429 (CS PHARMASCIENCES INC [US]); | [Y]EP3323817 (CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD [CN], et al); | [A]EP3492462 (SHENZHEN TARGETRX INC [CN]) | International search | [A]WO2017008761 (CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD [CN], et al); | [A]WO2018019204 (SHENZHEN TARGETRX INC [CN]); | [A]CN109328059 (CS PHARMASCIENCES INC) |